NR1H4 and cholestasis: In contrast, it has been suggested that FXR might function as negative regulator of MRP4 [88], which supports the concept that FXR antagonism (rather than its agonism) might be beneficial in cholestasis [89] by promoting the release of bile acids from hepatocytes into the systemic circulation [90].